These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Primary cutaneous anaplastic large-cell lymphoma with 6p25.3 rearrangement exhibits a biphasic histopathologic pattern: Two case reports and literature review. Xue YN; Wang Z; Sun JF; Chen H J Cutan Pathol; 2021 Dec; 48(12):1463-1470. PubMed ID: 34164830 [TBL] [Abstract][Full Text] [Related]
4. Primary Cutaneous Anaplastic Large-Cell Lymphoma With 6p25.3 Rearrangement in a Cardiac Transplant Recipient: A Case Report and Review of the Literature. Olson LC; Cheng E; Mathew S; Torres-Quinones M; Magro C Am J Dermatopathol; 2016 Jun; 38(6):461-5. PubMed ID: 26863058 [TBL] [Abstract][Full Text] [Related]
5. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders. Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854 [TBL] [Abstract][Full Text] [Related]
6. Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies. Wada DA; Law ME; Hsi ED; Dicaudo DJ; Ma L; Lim MS; Souza Ad; Comfere NI; Weenig RH; Macon WR; Erickson LA; Ozsan N; Ansell SM; Dogan A; Feldman AL Mod Pathol; 2011 Apr; 24(4):596-605. PubMed ID: 21169992 [TBL] [Abstract][Full Text] [Related]
7. Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis. Karai LJ; Kadin ME; Hsi ED; Sluzevich JC; Ketterling RP; Knudson RA; Feldman AL Am J Surg Pathol; 2013 Aug; 37(8):1173-81. PubMed ID: 23648461 [TBL] [Abstract][Full Text] [Related]
8. IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases. Pham-Ledard A; Prochazkova-Carlotti M; Laharanne E; Vergier B; Jouary T; Beylot-Barry M; Merlio JP J Invest Dermatol; 2010 Mar; 130(3):816-25. PubMed ID: 19812605 [TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options. Querfeld C; Khan I; Mahon B; Nelson BP; Rosen ST; Evens AM Oncology (Williston Park); 2010 Jun; 24(7):574-87. PubMed ID: 20669794 [TBL] [Abstract][Full Text] [Related]
10. Lymphomatoid papulosis with DUSP22-IRF4 rearrangement: A case report and literature review. Niu N; Heberton MM; Tang Z; Aung PP; Nagarajan P; Curry JL; Prieto VG; Torres-Cabala CA; Cho WC J Cutan Pathol; 2023 Aug; 50(8):711-716. PubMed ID: 36944579 [TBL] [Abstract][Full Text] [Related]
13. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414 [TBL] [Abstract][Full Text] [Related]
14. Loss of expression of 5-hydroxymethylcytosine in CD30-positive cutaneous lymphoproliferative disorders. De Souza A; Tinguely M; Pfaltz M; Burghart DR; Kempf W J Cutan Pathol; 2014 Dec; 41(12):901-6. PubMed ID: 25353265 [TBL] [Abstract][Full Text] [Related]
15. Anaplastic large cell lymphomas with the 6p25.3 rearrangement are a heterogeneous group of tumours with a diverse molecular background. Díaz de la Pinta FJ; Rodríguez Moreno M; Salgado RN; Carvajal García N; Santonja C; Pérez Buira S; Piris MA; Requena L; Manso R; Rodríguez-Pinilla SM Hum Pathol; 2023 Jul; 137():71-78. PubMed ID: 37127078 [TBL] [Abstract][Full Text] [Related]
16. Lymphomatoid Papulosis With DUSP22 Rearrangement in a Patient With a Historical Diagnosis of Primary Cutaneous Anaplastic Large Cell Lymphoma. Monika F; Li S; Ambler E; Cantu D; Siref A Cureus; 2024 Aug; 16(8):e66022. PubMed ID: 39221352 [TBL] [Abstract][Full Text] [Related]
17. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin. DeCoteau JF; Butmarc JR; Kinney MC; Kadin ME Blood; 1996 Apr; 87(8):3437-41. PubMed ID: 8605362 [TBL] [Abstract][Full Text] [Related]
19. Multiple cutaneous lymphoproliferative disorders showing a retained tumor clone by T-cell receptor gene rearrangement analysis: a case series of four patients and review of the literature. Stowman AM; Hsia LL; Kanner WA; Mahadevan MS; Bullock GC; Patterson JW Int J Dermatol; 2016 Feb; 55(2):e62-71. PubMed ID: 26266670 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders. Benner MF; Jansen PM; Meijer CJ; Willemze R Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]